These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37806439)

  • 1. The biosynthetic pathways of the protectins.
    Stenvik Haatveit Å; Hansen TV
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protectins: Their biosynthesis, metabolism and structure-functions.
    Vidar Hansen T; Serhan CN
    Biochem Pharmacol; 2022 Dec; 206():115330. PubMed ID: 36341938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
    Serhan CN; Chiang N; Dalli J
    Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel lipid mediator PD1
    Hansen TV; Dalli J; Serhan CN
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():103-110. PubMed ID: 28602942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
    Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
    Serhan CN; Chiang N
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
    Li QF; Hao H; Tu WS; Guo N; Zhou XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
    Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N
    Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
    Norling LV; Serhan CN
    J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review.
    Sun S; Yang D; Lv J; Xia H; Mao Z; Chen X; Gao Y
    Front Immunol; 2024; 15():1444740. PubMed ID: 39372413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.
    Serhan CN
    Mol Aspects Med; 2017 Dec; 58():1-11. PubMed ID: 28263773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages.
    Aursnes M; Tungen JE; Colas RA; Vlasakov I; Dalli J; Serhan CN; Hansen TV
    J Nat Prod; 2015 Dec; 78(12):2924-31. PubMed ID: 26580578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration.
    Serhan CN; Chiang N
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106718. PubMed ID: 36813255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.